🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Currently, adjuvant therapy is not recommended for patients with esophageal...
Status
Recruiting
Location
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Start Date
2018-11-01
Trial ID
NCT03731442
Treatments Being Tested
This initial cohort of this phase II trial studied the outcomes of using a ...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-02-09
Trial ID
NCT04370301
Treatments Being Tested
Anthracycline-containing regimens are recommended as adjuvant treatment for...
Status
Completed
Location
University Hospital of Crete
Start Date
2004-08
Trial ID
NCT00431080
This study attempts to employ a combination therapy using rhG-CSF, IL-2, an...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-10
Trial ID
NCT06504901
Treatments Being Tested
A multicenter, open, one-arm clinical study evaluated the efficacy and safe...
Status
Unknown
Location
Sun Yat-sen University Cancer Hospital
Start Date
2019-02-22
Trial ID
NCT03870412
Treatments Being Tested
The aim of this study is to evaluate Plerixafor (MOZOBIL) plus recombinant ...
Status
Completed
Location
Chaim Sheba Medical Center
Start Date
2010-06
Trial ID
NCT01164345
Treatments Being Tested
This trial will compare 6 versus 12 months of trastuzumab in combination wi...
Status
Completed
Location
University Hospital of Crete
Start Date
2004-10
Trial ID
NCT00615602
The main treatments for non-Hodgkin's lymphoma are surgery, radiotherapy, c...
Status
Unknown
Location
The fourth hospital of Hebei Medical University
Start Date
2019-01-01
Trial ID
NCT04497688
Treatments Being Tested
This phase I/II trial finds the best dose, side effects and how well giving...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-02-04
Trial ID
NCT04797767
REGIME is comparing two treatments, with Darbepoetin Alpha (DA) and Filgras...
Status
Completed
Location
Birmingham Cancer Research UK Clinical Trial Unit
Start Date
2010-11-01
Trial ID
NCT01196715
Treatments Being Tested